RecruitingLiver FibrosisHepatic Cirrhosis

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

Eligible age

18+ yrs

Accepts

All genders

Locations

9 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to evaluate the safety, tolerability, and pharmacodynamic effects of AZD2389 in adult participants with steatotic liver disease (SLD) and advanced fibrosis.

Sponsor: AstraZeneca

Where it's recruiting

Arizona

Chandler

Florida

Jupiter · Miami · Port Orange

Missouri

Kansas City · St Louis

Nevada

Las Vegas

North Carolina

Morehead City · Raleigh

Westlake

Yukon

Clarksville

Austin · Denison · Georgetown · Houston …

Source: ClinicalTrials.gov · NCT07610837 · last updated 2026-05-28